Generic drugs approved by FDA (through April 2008) including cefuroxime for oral suspension, pramipexole tablets, alendronate once-daily tablets, and alendronate once-weekly tablets.
Cefuroxime for oral suspension, 125 and 250 mg/5 mL (equiv to Ceftin for oral suspension)
RANBAXY
Pramipexole tablets, 0.125, 0.25, 0.5, 1, and 1.5 mg (equiv to Mirapex tablets)
Alendronate once-daily tablets, 5, 10, and 40 mg, and once-weekly tablets, 35 mg (equiv to Fosamax tablets)
TEVA
Alendronate once-weekly tablets, 70 mg (equiv to Fosamax tablets)
TEVA, BARR
FDA Approves Combination Therapy for Pulmonary Arterial Hypertension
March 25th 2024J&J’s Opsynvi is single-tablet combination of macitentan, an endothelin receptor antagonist, and tadalafil, a PDE5 inhibitor. It will be priced on parity with Opsumit, which is also a J&J product to treat patients with PAH.